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When bioinformaticist Steve Brenner
was finishing his postdoc at Stanford
University and looking for a job, an
important issue was that his
employment contract would allow
him to contribute to ‘open-source’
software — software where the
source code is freely available, and
derivative works can be made and
redistributed. Unlike many of his
colleagues, Brenner knew that most
universities prohibit the free
distribution of software, and indeed,
at the University of California,
Berkeley, he found this to be the
case. “I found that their rules were in
fact incompatible with open-source
licenses,” he says.
Brenner, now at Berkeley,
decided to negotiate his contract
before he accepted the position. A
separate statement was ultimately
added, allowing him to contribute to
open-source software as long as all
the contributors to the software
agreed, the funding agency agreed,
and it didn’t violate any laws.
Although he stresses that Berkeley
was very accommodating, he says
that the process was time-consuming,
confusing, and expensive, requiring
him to hire a lawyer. “The biggest
issue was simply that they’d never
done anything like this before, so no
one really knew what the process
would be,” he says.
Open-source enthusiasts say that
open-source software — which
powers much of the Internet and
operating systems such as Linux —
allows software to improve and
evolve faster than if the source code
were not freely available. But many
academic bioinformaticists have been
unaware that their universities
usually own the copyright to their
work, including software, so they
aren’t legally free to distribute their
software without permission from
their institution’s technology transfer
office. “Most people probably
distribute their software off their
websites and their universities
wouldn’t care, because most of this
stuff isn’t commercializable anyway,”
says bioinformaticist Sean Eddy at
Washington University in St. Louis,
Missouri. But for potentially
commercializable software, the
technology transfer office would take
notice, he says. 
If there is one certainty, it is that
every university in the US has a
different policy on copyright
Even academic technology transfer
offices aren’t uniform on their
copyright policies, according to
Karen Hersey, a lawyer with the
Massachusetts Institute of
Technology and past president of the
Association of University
Technology Managers. “If there’s
one certainty, it is that every
university in the US has a different
policy on copyright, who owns what
copyrightable materials, and how
they should be distributed,” she
says. Assuming the funding agency
has no specific requirements, the
decision ultimately depends on the
wishes of the investigator and the
technology transfer office, she says. 
This contrasts with the more
uniform US university patent policy
due to the 1980 Bayh–Dole Act,
which allows universities to patent
and commercialize discoveries made
with federal funds. “We’re definitely
caught in a vice here because we
have conflicting mandates,” says
Eddy. On the one hand, the
Bayh–Dole Act encourages
discoveries to be commercialized, yet
granting agencies say that anything
researchers develop must be made
freely available, he notes. Whether
this explicitly applies to software
hasn’t been clear, he says. One
exception is the Howard Hughes
Medical Institute, which has
included software among the
research tools that should be made
freely available, encouraging that the
source code be made available for
modification for non-commercial
purposes and discouraging exclusive
commercial licenses. 
Working with funding agencies is
one way to keep software open
source, says bioinformaticist Ewan
Birney of the European
Bioinformatics Institute at Hinxton,
near Cambridge, UK. For the
Ensembl project, which he co-heads,
“we deliberately said to the
Wellcome Trust that we’re going to
make this software open, and they
supported that,” he says. 
In a similar vein, Jason Stewart,
who heads the private consulting
company openinformatics.com in
Tuscon, Arizona, has started a
petition asking public funding
agencies such as the National
Institutes of Health and the National
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Science Foundation to require that
all funded software projects be
released as open source. Stewart and
his colleagues have also argued in a
paper being considered for
publication in Briefings in
Bioinformatics that since most
bioinformatics software is customized
for particular applications, having the
algorithm available through the
source code is important for the peer-
review process. 
Brenner has proposed having a
standard employment contract that
could be used to allow researchers at
any institution to produce open-
source software. The effort is still in
nascent stages, he says, but there are
people working on different versions
of the contract, such as versions for
Americans or Europeans at academic
institutions, or people who work at
companies who want to produce
open-source software in their spare
time.
And bioinformaticists point out
that there’s a simple solution: to have
the option of licensing software
under an open-source license or a
commercial license. “In the case
where you have a sole copyright
holder, and that’s true for all our
software, the copyright holder can
distribute under any license they feel
like,” says Eddy. But “you’ve got to
be pretty savvy to get yourself into
that situation,” says Birney. 
But ultimately, both
bioinformaticists and lawyers seem to
agree that it’s ultimately the
investigator’s decision about how
they want to license their software.
Brenner says that although his
modified contract could cause
Berkeley to lose out on
commercialization opportunities, ‘the
university’s primary goal is not to
make money but to foster
knowledge, and I think that they saw
this as being something where the
cost involved was worth the
benefits.’
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